CBC·3 min read·medium
Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo
✦AI Summary
Health Canada has authorized a Phase 1 clinical trial for a Moderna mRNA vaccine candidate targeting the Bundibugyo strain of the Ebola virus. This move follows a severe outbreak in Congo and aims to establish safety and dosing standards for the vaccine.
Federal officials announced the recent authorization of Moderna’s mRNA shot on Tuesday, making Canada just the second country to launch a Phase 1 clinical trial for a Bundibugyo vaccine candidate after the U.K.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in